Covered recipient · General Payments record
JEFFREY STEVEN BANK
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,209.36
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $613.08 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $287.70 | 18 |
| Lilly USA, LLC | $102.93 | 3 |
| Celgene Corporation | $97.33 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.89 | 3 |
| Phathom Pharmaceuticals, Inc. | $19.87 | 1 |
| Janssen Biotech, Inc. | $19.42 | 1 |
| SHIELD THERAPEUTICS INC | $17.43 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $16.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.79 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275331 | CMS |
| ABBVIE INC. | $17.70 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275333 | CMS |
| ABBVIE INC. | $20.05 | 03/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275335 | CMS |
| ABBVIE INC. | $13.89 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275337 | CMS |
| ABBVIE INC. | $19.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275339 | CMS |
| ABBVIE INC. | $17.72 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275341 | CMS |
| ABBVIE INC. | $22.07 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275343 | CMS |
| ABBVIE INC. | $25.00 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275345 | CMS |
| ABBVIE INC. | $21.18 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275347 | CMS |
| ABBVIE INC. | $15.96 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275349 | CMS |
| ABBVIE INC. | $19.55 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275351 | CMS |
| ABBVIE INC. | $0.68 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275353 | CMS |
| ABBVIE INC. | $1.84 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275355 | CMS |
| ABBVIE INC. | $14.77 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275357 | CMS |
| ABBVIE INC. | $17.12 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275359 | CMS |
| ABBVIE INC. | $19.79 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275361 | CMS |
| ABBVIE INC. | $14.08 | 11/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275363 | CMS |
| ABBVIE INC. | $3.41 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103275365 | CMS |
| Celgene Corporation | $23.91 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101191987 | CMS |
| Celgene Corporation | $20.70 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101191989 | CMS |
| Celgene Corporation | $21.93 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101191991 | CMS |
| Celgene Corporation | $14.87 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101191995 | CMS |
| Celgene Corporation | $15.92 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101191997 | CMS |
| Intercept Pharmaceuticals, Inc. | $16.51 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113635256 | CMS |
| Janssen Biotech, Inc. | $19.42 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078566521 | CMS |
| Lilly USA, LLC | $16.19 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135055464 | CMS |
| Lilly USA, LLC | $69.58 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135012031 | CMS |
| Lilly USA, LLC | $17.16 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135055670 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.87 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151038184 | CMS |
| SHIELD THERAPEUTICS INC | $17.43 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150154506 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.77 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137480077 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.63 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137480080 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.49 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137480084 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.